From Name:
From Email:
To Name:
To Email:

Optional Message:

FDA approves new hepatitis C treatment

from Healthline

The U.S. Food and Drug Administration approved Johnson & Johnson's new hepatitis C drug, which has been hailed as a cure for the infectious disease that's believed to affect 3.2 million Americans. The drug, Olysio, and others being used to treat the disease are giving patients — including many aging baby boomers — a new lease on life. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063